BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29654579)

  • 41. [Applications of chromatography-mass spectrometry in metabonomics].
    Huang Q; Yin P; Lu X; Kong H; Xu G
    Se Pu; 2009 Sep; 27(5):566-72. PubMed ID: 20073191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Qi Y; Song Y; Gu H; Fan G; Chai Y
    Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MET-XAlign: a metabolite cross-alignment tool for LC/MS-based comparative metabolomics.
    Zhang W; Lei Z; Huhman D; Sumner LW; Zhao PX
    Anal Chem; 2015 Sep; 87(18):9114-9. PubMed ID: 26247233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemical derivatization-based LC-MS for metabolomics: advantages and challenges.
    Jiang R; Jiao Y; Xu F
    Bioanalysis; 2016 Sep; 8(18):1881-3. PubMed ID: 27522940
    [No Abstract]   [Full Text] [Related]  

  • 45. What can we do to refine the redundant data in LC-MS and GC-MS based metabolomics?
    Chen J; Xu F
    Bioanalysis; 2017 Feb; 9(3):235-238. PubMed ID: 28084787
    [No Abstract]   [Full Text] [Related]  

  • 46. Urinary metabonomics of stomach cancer assessed by rapid resolution liquid chromatography/time-of-fight mass spectrometry.
    Zhang Y; Ren H; Jiang Y; Gao YF; Liu SY
    Chin Med J (Engl); 2013; 126(10):1930-3. PubMed ID: 23673112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
    Alberice JV; Amaral AF; Armitage EG; Lorente JA; Algaba F; Carrilho E; Márquez M; García A; Malats N; Barbas C
    J Chromatogr A; 2013 Nov; 1318():163-70. PubMed ID: 24139504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of valproic acid-induced endogenous and exogenous metabolite alterations using LC-MS-based metabolomics.
    Sun J; Schnackenberg LK; Hansen DK; Beger RD
    Bioanalysis; 2010 Feb; 2(2):207-16. PubMed ID: 21083304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurement of Metabolome Samples Using Liquid Chromatography-Mass Spectrometry, Data Acquisition, and Processing.
    Pluskal T; Yanagida M
    Cold Spring Harb Protoc; 2016 Dec; 2016(12):. PubMed ID: 27934688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of coverage, retention patterns, and selectivity of seven liquid chromatographic methods for metabolomics.
    Wernisch S; Pennathur S
    Anal Bioanal Chem; 2016 Sep; 408(22):6079-91. PubMed ID: 27370688
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improving metabolome coverage and data quality: advancing metabolomics and lipidomics for biomarker discovery.
    Vuckovic D
    Chem Commun (Camb); 2018 Jun; 54(50):6728-6749. PubMed ID: 29888773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics.
    Kumar BS; Chung BC; Kwon OS; Jung BH
    J Appl Toxicol; 2012 Jul; 32(7):505-20. PubMed ID: 22131085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic phenotyping by liquid chromatography-mass spectrometry to study human health and disease.
    Wilson ID
    Anal Chem; 2015 Mar; 87(5):2519. PubMed ID: 25693762
    [No Abstract]   [Full Text] [Related]  

  • 54. Hyphenated MS-based targeted approaches in metabolomics.
    Begou O; Gika HG; Wilson ID; Theodoridis G
    Analyst; 2017 Aug; 142(17):3079-3100. PubMed ID: 28792021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in separation science applied to metabonomics.
    Xiayan L; Legido-Quigley C
    Electrophoresis; 2008 Sep; 29(18):3724-36. PubMed ID: 18850642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ensuring Fact-Based Metabolite Identification in Liquid Chromatography-Mass Spectrometry-Based Metabolomics.
    Theodoridis G; Gika H; Raftery D; Goodacre R; Plumb RS; Wilson ID
    Anal Chem; 2023 Feb; 95(8):3909-3916. PubMed ID: 36791228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted full-scan LC-MS metabolomics: simultaneous quantitation of knowns and feature discovery provide the best of both worlds.
    Rosebrock AP
    Bioanalysis; 2017 Jan; 9(1):5-8. PubMed ID: 27921451
    [No Abstract]   [Full Text] [Related]  

  • 58. New Methodology for Known Metabolite Identification in Metabonomics/Metabolomics: Topological Metabolite Identification Carbon Efficiency (tMICE).
    Sanchon-Lopez B; Everett JR
    J Proteome Res; 2016 Sep; 15(9):3405-19. PubMed ID: 27490438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
    Peng J; Chen YT; Chen CL; Li L
    Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis.
    Inoue K; Tsuchiya H; Takayama T; Akatsu H; Hashizume Y; Yamamoto T; Matsukawa N; Toyo'oka T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 974():24-34. PubMed ID: 25463194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.